A little over two years after Lyndra Therapeutics Inc. first unveiled its technology for time-delayed drug delivery through a simple pill, the company has raised $55 million to continue developing the technology for public consumption. By creating a new kind of ultra long-acting drug delivery mechanism in pills, the company claims it can remove the […]...